You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis,%20Chronic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial (Imdusiran (AB-729))

Not yet recruiting
  • Chronic Hepatitis B
  • Imdusiran (AB-729)
  • (no location specified)
Nov 30, 2023

Safety and Biomarkers of Bulevirtide Treatment in Chronic

Recruiting
  • Chronic Hepatitis D
  • Stockholm, Sweden
    Karolinska University Hospital, Department of Infectious Disease
Sep 27, 2023

Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

Recruiting
  • Chronic Hepatitis b Patients
  • Tenofovir Disoproxil Fumarate and Entcavir
  • Sohag, Egypt
    Sohag University hospitals
May 22, 2023

Chronic Hepatitis D Infection Trial in Changchun (Hepalatide, Hepalatide Placebo)

Not yet recruiting
  • Chronic Hepatitis D Infection
  • Changchun, China
    The first hospital of Jilin University
Apr 22, 2023

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

Not yet recruiting
  • Chronic Hepatitis B Patients
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 15, 2023

    Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

    Recruiting
    • Chronic Hepatitis D
      • Moscow, Russian Federation
        Center of Target Therapy
      Nov 6, 2023

      Chronic Hepatitis b Trial (CB06-036, Placebo)

      Not yet recruiting
      • Chronic Hepatitis b
      • (no location specified)
      Apr 12, 2023

      Chronic Hepatitis D Infection Trial (Bulevirtide)

      Not yet recruiting
      • Chronic Hepatitis D Infection
      • Bulevirtide
      • (no location specified)
      Jan 30, 2023

      Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

      Enrolling by invitation
      • Chronic Hepatitis B
      • Non-alcoholic Fatty Liver Disease
      • exercise
      • Taipei, Zhongzheng Dist., Taiwan
        National Taiwan University Hospital
      Jul 13, 2023

      Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

      Not yet recruiting
      • Hepatitis B, Chronic
      • Exposure factors
      • (no location specified)
      Sep 10, 2023

      Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound

      Not yet recruiting
      • Hepatic Steatosis
      • +2 more
        • Seoul, Korea, Republic of
          Asan Medical Center
        May 21, 2023

        Hepatic Steatosis and Chronic Hepatitis B Virus

        Not yet recruiting
        • Chronic Hepatitis
        • Liver biopsy
        • Sohag, Egypt
          Faculty of medicine
        Dec 28, 2022

        Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

        Not yet recruiting
        • Chronic Hepatitis Delta Virus Infection
        • HH-003(20mg/kg)
        • +2 more
        • (no location specified)
        May 7, 2023

        Chronic Hepatitis B Trial in Beijing (TCR-T)

        Active, not recruiting
        • Chronic Hepatitis B
        • TCR-T
        • Beijing, China
          The Fifth Medical Center of PLA General Hospital
        Jun 13, 2023

        Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

        Not yet recruiting
        • Chronic Hepatitis B
        • HRS9950 tablets
        • HRS9950 placebo tablets
        • (no location specified)
        Jun 7, 2023

        After Long-Term Antiviral Treatment for Chronic Hepatitis B

        Completed
        • Chronic Hepatitis B e Antigen Positive
        • Chronic Hepatitis B e Antigen Negative
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 26, 2023

          Protease Inhibitors in Chronic Hepatitis C

          Completed
          • Chronic Hepatitis C
            • Graz, Austria
              Department of Internal Medicine, Medical University of Graz
            Jan 11, 2023

            Metabolic Syndrome on Antiviral Response in People With Chronic

            Not yet recruiting
            • Chronic Hepatitis b
              • (no location specified)
              Jan 21, 2023

              Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

              Active, not recruiting
              • Chronic Hepatitis B
              • Guangzhou, Guangdong, China
                Nanfang Hospital, Southern Medical University
              Apr 20, 2023

              Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

              Recruiting
              • Chronic Hepatitis b
              • Non-Alcoholic Fatty Liver Disease
                • Beijing, Select A State Or Province, China
                  Yameng Sun
                Mar 27, 2023

                COVID-19 Infection and Its Clinical Prognosis in Chronic

                Recruiting
                • Chronic Hepatitis B
                • COVID-19 Infection
                • Beijing, Beijing, China
                  Department of Hepatology Division 2, Beijing Ditan Hospital
                Mar 28, 2023

                Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

                Not yet recruiting
                • Chronic Hepatitis B
                • (no location specified)
                Feb 28, 2023

                Chronic Hepatitis B Trial in Grafton (AHB-137 injection, Placebo)

                Not yet recruiting
                • Chronic Hepatitis B
                • AHB-137 injection
                • Placebo
                • Grafton, Auckland, New Zealand
                  New Zealand Clinical Research
                Jan 29, 2023

                Chronic Hepatitis B Trial (HRS-5635, Placebo)

                Not yet recruiting
                • Chronic Hepatitis B
                • (no location specified)
                Mar 29, 2023